Tracking dynamics of muscle engraftment in small animals by in vivo fluorescent imaging

Journal of Visualized Experiments

Volumn , Issue 31, 2009, Pages

  Yang, Zhong ^a   Zeng, Qing ^a   Ma, Zhiyuan ^a   Wang, Yaming ^a   Xu, Xiaoyin ^a  

^a Brigham and Womens's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80055121706     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/1388     Document Type: Article

References (16)

1. Ballou, B., L.A. Ernst and A.S. Waggoner. Fluorescence imaging of tumors in vivo. Curr Med Chem. 12(7): 795-805 (2005).
2. Chalfie, M., Y. Tu, G. Euskirchen, W.W. Ward and D.C. Prasher. Green fluorescent protein as a marker for gene expression. Science. 263 (5148): 802-5 (1994).
3. Godavarty, A., E.M. Sevick-Muraca and M.J. Eppstein. Three-dimensional fluorescence lifetime tomography. Med Phys. 32(4): 992-1000 (2005).
4. Graves, E.E., R. Weissleder and V. Ntziachristos. Fluorescence molecular imaging of small animal tumor models. Curr Mol Med. 4(4): 419-30 (2004).
5. Graves, E.E., D. Yessayan, G. Turner, R. Weissleder and V. Ntziachristos. Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. J Biomed Opt. 10(4): 44019 (2005).
6. Gurfinkel, M., S. Ke, X. Wen, C. Li and E.M. Sevick-Muraca. Near-infrared fluorescence optical imaging and tomography. Dis Markers. 19 (2-3): 107-21 (2003).
7. Lee, J. and E.M. Sevick-Muraca. Three-dimensional fluorescence enhanced optical tomography using referenced frequency-domain photon migration measurements at emission and excitation wavelengths. J Opt Soc Am A Opt Image Sci Vis. 19(4): 759-71 (2002).
8. Xu, X., Z. Yang, Q. Liu and Y. Wang. 2008. In vivo fluorescence imaging of muscle regeneration by transplanted eGFP-labeled myoblasts. in Annual Meeting of American Society of Gene Therapy. p. 268. Boston, MA: ASGT.
9. Hoffman, R.M. In vivo cell biology of cancer cells visualized with fluorescent proteins. Curr Top Dev Biol. 70: 121-44 (2005).
10. Coulton, G.R., J.E. Morgan, T.A. Partridge and J.C. Sloper. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol. 14(1): 53-70 (1988).
11. Morgan, J.E. and T.A. Partridge. Muscle satellite cells. Int J Biochem Cell Biol. 35(8): 1151-6 (2003).
12. Mendell, J.R., J.T. Kissel, A.A. Amato, W. King, L. Signore, T.W. Prior, Z. Sahenk, S. Benson, P.E. McAndrew, R. Rice and et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med. 333(13): 832-8 (1995).
13. Bogdanovich, S., K.J. Perkins, T.O. Krag and T.S. Khurana. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med. 82(2): 102-15 (2004).
14. Morgan, J.E., G.R. Coulton and T.A. Partridge. Mdx muscle grafts retain the mdx phenotype in normal hosts. Muscle Nerve. 12(5): 401-9 (1989).
15. Sherwood, R.I., J.L. Christensen, I.L. Weissman and A.J. Wagers. Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells. 22(7): 1292-304 (2004).
16. Cerletti, M., S. Jurga, C.A. Witczak, M.F. Hirshman, J.L. Shadrach, L.J. Goodyear and A.J. Wagers. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell. 134(1): 37-47 (2008).